Clinical Trial Update: A Study of SHR-4375 in Subjects With Solid Tumors [Phase 1, Phase 2]

View source ↗

Summary

A clinical trial update indicates that SHR-4375 is being studied in Phase 1/2 for patients with solid tumors, with recruitment ongoing.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Solid Tumors

Drugs mentioned

• SHR-4375

Snippet

Sponsor: Suzhou Suncadia Biopharmaceuticals Co., Ltd. | Conditions: Solid Tumors | Phase 1, Phase 2 | Status: RECRUITING